8.0 Introduction
Summary
Both DR and DME are defined into clinical classifications. In this Module, you will learn about: Focal/Diffuse DME, DR Severity Scale, and Proposed Phenotypes of DR/DME.
- Syllabus
- Pre-Survey
- 1 Background
- 2 Diabetes
- 3 Diabetic Eye Disease
- 4 Role of Blood Vessels
- 5 The Retina
-
6 DR/DME Etiology
- 6.0 Introduction
-
Graded Section
6.1 Metabolic Pathway to DME -
Graded Section
6.2 Hyperglycemia -
Graded Section
6.3 PKC -
Graded Section
6.4 Oxidative Stress -
Graded Section
6.5 AGEs -
Graded Section
6.6 Polyol Pathway -
Graded Section
6.7 Hexosamine Pathway -
Graded Section
6.8 R-A System -
Graded Section
6.9 Inflammation -
Graded Section
6.10 Retinal Vessel Changes (include hypertension) -
Graded Section
6.11 Retinal Changes and Edema -
Graded Section
6.12 Summary
- 7 DR/DME Diagnosis
- 8 DR/DME Classifications
-
9 Treatments
- 9.0 Introduction
-
Graded Section
9.1 Anti-VEGF Treatments -
Graded Section
9.2 Biology and pharmacology of anti-VEGF therapies -
Graded Section
9.3 Avastin -
Graded Section
9.4 Lucentis -
Graded Section
9.5 Eylea -
Graded Section
9.6 Side Effects -
Graded Section
9.7 Laser Therapy -
Graded Section
9.8 Corticosteroids -
Graded Section
9.9 Vitrectomy -
Graded Section
9.10 Future Technology -
Graded Section
9.11 Assessment of treatment value -
Graded Section
9.12 Summary
-
10 Clinical Studies & Treatment Data
- 10.0 Introduction
-
Graded Section
10.1 READ-2 -
Graded Section
10.2 RESOLVE -
Graded Section
10.3 FAME -
Graded Section
10.4 BOLT -
Graded Section
10.5 DRCR.net Protocol I -
Graded Section
10.6 CHAMPLAIN -
Graded Section
10.7 RIDE/RISE -
Graded Section
10.8 PLACID -
Graded Section
10.9 MEAD -
Graded Section
10.10 RESTORE -
Graded Section
10.11 VIVID/VISTA -
Graded Section
10.12 DRCR.net Protocol T -
Graded Section
10.13 Ongoing Studies -
Graded Section
10.14 Summary: Putting It All Together
- Exit-Survey